Week of January 31, 2023 | Vol. 12, Issue 4

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates



Quick Links

Who We Are

M&A Discussion Group

Daybreak Consumer Care

Carlin Consumer Health


Contact Information

Xan Smith

Managing Director

Business Development

xsmith@bourne-partners.com


Jeremy C. Johnson

Managing Director

Head of M&A and Capital Advisory

jjohnson@bourne-partners.com

Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners

SCOPE Summit for Clinical Ops Executives

February 6-9, 2023 - Orlando, FL

CPHA 2023

March 19-21, 2023 - Orlando, FL

DCAT Week 2023

March 20-23, 2023 - New York City, NY

INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A TRANSACTIONS

Pharma & Biotech

6 transactions totaling $9 million


Supplies, Equipment & Services

16 transactions totaling $2 billion


Healthcare Facilities & Distributors

6 transactions


Healthcare IT & Managed Care

7 transactions totaling $92 million

PRIVATE PLACEMENTS

Pharma & Biotech

18 transactions totaling $188 million


Supplies, Equipment & Services

18 transactions totaling $171 million


Healthcare Facilities & Distributors

3 transactions


Healthcare IT & Managed Care

11 transactions totaling $88 million

PUBLIC OFFERINGS

Pharma & Biotech

18 transactions totaling $867 million


Supplies, Equipment & Services

13 transactions totaling $464 million


Healthcare Facilities & Distributors

1 transaction totaling $100 million


Healthcare IT & Managed Care

0 transactions

TRADING COMPS
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.






MARKET REPORTS
Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A PIPELINE

Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider


Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform


Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product


Project Gateway

Pharma | Sell-Side

Acquisition opportunity of US specialty generics platform and small portfolio

Project Jazz

Pharma Services | Sell-Side

Acquisition opportunity of US compounding pharmacy and pharmacy services provider


Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 


Project Power Play

Pharma | Buy-Side

Seeking established brands across all therapeutic categories or growth assets in Neurology / CNS


Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

FEATURED HEADLINES

A Sampling of Industry Headlines

Formulated Solutions announces Founder Eric Dann assumes Executive Chairman role and Victor Swint appointed CEO

Formulated Solutions - Jan 17, 2023

Amazon Pharmacy rolls out service for unlimited generic drug prescriptions for $5 a month

Fierce Healthcare - Jan 24, 2023

TFS HealthScience snaps up niche CRO Appletree in ophthalmology expansion

Fierce Biotech - Jan 25, 2023

List Labs Expands Manufacturing Capacity

Contract Pharma - Jan 26, 2023

Catalent Bolsters Cell and Gene Services

Contract Pharma - Jan 26, 2023

Pasithea Signs CMC Development and Manufacturing Agreement

Contract Pharma - Jan 26, 2023

Experic Expands Analytical Capabilities and Facilities

Contract Pharma - Jan 26, 2023

TANNER NEWS

Linkedin  

Managing aggressive timelines for clinical trials

Sourcing clinical trial products and distributing them in accordance with strict timelines and country-specific regulations can make or break a trial’s success. In this article, we offer insights on clinical trial sourcing and supply and share our approach to meeting aggressive timelines. Learn more.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.